PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30321197-0	2018	The small molecule rhodomyrtone suppresses TNF-alpha and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.	rhodomyrtone	19-31	tumor necrosis factor	Homo sapiens	43-52	
30321197-4	2018	This study assessed the potential of rhodomyrtone for curtailing TNF/IL-17A-driven inflammation.	rhodomyrtone	37-49	tumor necrosis factor	Homo sapiens	65-68	
30321197-5	2018	Stimulating human skin organ cultures with TNF+IL-17A to model the skin inflammation in psoriasis, we found that rhodomyrtone significantly decreased inflammatory gene expression and the expression and secretion of inflammatory proteins, assessed by qRT-PCR, immunohistochemistry and ELISA assays respectively.	rhodomyrtone	113-125	tumor necrosis factor	Homo sapiens	43-46	
30321197-6	2018	RNA-seq analysis of monolayer primary keratinocytes treated with IL-17A/TNF showed that rhodomyrtone inhibited 724/1587 transcripts >2-fold altered by IL-17A/TNF (p<0.01), a number of which were confirmed at the mRNA and protein level.	rhodomyrtone	88-100	tumor necrosis factor	Homo sapiens	72-75	
30321197-6	2018	RNA-seq analysis of monolayer primary keratinocytes treated with IL-17A/TNF showed that rhodomyrtone inhibited 724/1587 transcripts >2-fold altered by IL-17A/TNF (p<0.01), a number of which were confirmed at the mRNA and protein level.	rhodomyrtone	88-100	tumor necrosis factor	Homo sapiens	161-164	
30321197-7	2018	Suggesting that rhodomyrtone acts by modulating MAP kinase and NF-kappaB signaling pathways, rhodomyrtone inhibited TNF-induced ERK, JNK, p38, and NF-kappaBp65 phosphorylation.	rhodomyrtone	93-105	tumor necrosis factor	Homo sapiens	116-119